Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By PET Confirmation

Launched by NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · Nov 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment approach for patients with bone cancer that has spread to the spine, known as metastatic spine lesions. The researchers want to see if using a combination of radiofrequency ablation (a technique that uses heat to destroy cancer cells) along with a process called augmentation (which helps stabilize the spine) can effectively change the metabolism of these lesions. They will use a special device called Osteocool-Medtronic and check the results with a PET-CT scan to see how well the treatment worked.

To be eligible for this trial, participants must be between 65 and 74 years old and have one to three active spine tumors that are currently metabolically active, as shown by a PET-CT scan done within the last month. Participants will need to sign an informed consent form, meaning they understand the study and agree to participate. After the treatment, they will have another PET-CT scan to check the effectiveness of the procedure. This trial is currently looking for volunteers to help improve treatment options for those facing this challenging condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • only patients with secondary osteolytic and mixed (lytic and sclerotic) spine tumors with one to three active lesions will be enrolled.
• • lesions to be treated must be metabolically active on PET-CT performed during the last month.
• • Patients will be informed and sould sign an inform consent.
• • post treatment patients should submittes a new PET-CT in order to verify the activity of the treated area.
• Exclusion Criteria:
• • -